UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Helicobacter pylori-associated immune thrombocytopenia:Clinical features and pathogenic mechanisms

World journal of gastroenterology : WJG, 2014-01, Vol.20 (3), p.714-723

Kuwana, Masataka

2014

Link zum Volltext

Verfügbarkeit prüfen

Symposium 3: Improving the Outcome of Systemic Sclerosis

Journal of clinical rheumatology and immunology (Online), 2023-11, Vol.23 (Supp01), p.11-11

KUWANA, Masataka

2023

Link zum Volltext

Verfügbarkeit prüfen

Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2017, Vol.84 (2), p.56

Kuwana, Masataka

2017

Link zum Volltext

Verfügbarkeit prüfen

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

The New England journal of medicine, 2019-06, Vol.380 (26), p.2518-2528

2019

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities

Journal of Scleroderma and Related Disorders, 2017-09, Vol.2 (3), p.137-152

2017

Link zum Volltext

Verfügbarkeit prüfen

Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision

International journal of hematology, 2020-03, Vol.111 (3), p.329-351

2020

Link zum Volltext

Verfügbarkeit prüfen

Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies

Clinical rheumatology, 2020-11, Vol.39 (11), p.3489-3497

2020

Link zum Volltext

Verfügbarkeit prüfen

Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease

Modern rheumatology, 2020-03, Vol.30 (2), p.225-231

2020

Link zum Volltext

Verfügbarkeit prüfen

Strategies for regulating tissue fibrosis and their clinical application

Inflammation and regeneration, 2020-04, Vol.40, p.6-6

Kuwana, Masataka

2020

Link zum Volltext

Verfügbarkeit prüfen

Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease

Rheumatology (Oxford, England), 2021-01, Vol.60 (1), p.250-255

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease

Modern rheumatology, 2013-05, Vol.23 (3), p.496-502

2013

Link zum Volltext

Verfügbarkeit prüfen

Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis

Arthritis research & therapy, 2022-08, Vol.24 (1), p.1-194, Article 194

2022

Link zum Volltext

Verfügbarkeit prüfen

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

Annals of the rheumatic diseases, 2020-05, Vol.79 (5), p.626

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders

Therapeutic Advances in Musculoskeletal Disease, 2021, Vol.13, p.1759720X211032457-1759720X211032457

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease

PloS one, 2020-03, Vol.15 (3), p.e0229997-e0229997

2020

Link zum Volltext

Verfügbarkeit prüfen

Updates on genetics in systemic sclerosis

Inflammation and regeneration, 2021-06, Vol.41 (1), p.1-17

2021

Link zum Volltext

Verfügbarkeit prüfen

Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus

PloS one, 2020-01, Vol.15 (1), p.e0227069-e0227069

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for myositis-associated interstitial lung disease

PloS one, 2014-06, Vol.9 (6), p.e98824-e98824

2014

Link zum Volltext

Verfügbarkeit prüfen

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome

PloS one, 2013-04, Vol.8 (4), p.e60442-e60442

2013

Link zum Volltext

Verfügbarkeit prüfen

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis & rheumatology (Hoboken, N.J.), 2019-06, Vol.71 (6), p.972-982

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies

Clinical reviews in allergy & immunology, 2023-06, Vol.64 (3), p.239-261

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

PloS one, 2017-08, Vol.12 (8), p.e0181692-e0181692

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease

PloS one, 2017-11, Vol.12 (11), p.e0187580

2017

Link zum Volltext

Verfügbarkeit prüfen

A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus

Arthritis research & therapy, 2020-04, Vol.22 (1), p.88-88, Article 88

2020

Link zum Volltext

Verfügbarkeit prüfen

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome

PloS one, 2016-06, Vol.11 (6), p.e0156407-e0156407

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 831

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(670)
Mit Volltextzugriff
(731)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(548)
Humans
(495)
Rheumatology
(365)
Life Sciences & Biomedicine
(359)
Female
(338)
Male
(319)
Middle Aged
(280)
Adult
(233)
Multidisciplinary Sciences
(189)
Science & Technology - Other Topics
(189)
Aged
(180)
Patients
(175)
Medicine
(149)
Medicine And Health Sciences
(138)
Biology And Life Sciences
(134)
Arthritis
(124)
Rheumatoid Arthritis
(115)
Immunology
(112)
Biological And Medical Sciences
(100)
Medical Sciences
(97)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Helicobacter pylori-associated immune thrombocytopenia:Clinical features and pathogenic mechanisms

Symposium 3: Improving the Outcome of Systemic Sclerosis

Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities

Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision

Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies

Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease

Strategies for regulating tissue fibrosis and their clinical application

Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease

Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease

Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders

Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease

Updates on genetics in systemic sclerosis

Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus

Prognostic factors for myositis-associated interstitial lung disease

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease

A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome

Suchergebnisse filtern